This meta-analysis included 12,453 breast cancer cases and 14,056 controls, and was used to evaluate reported associations between breast cancer risk and the +331G/A (rs10895068) functional polymorphism in the PgR gene promoter. The gene discussed is PGR; the disease is breast carcinoma.